This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Halozyme Therapeutics Inc (HALO)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 61.39M 27.36M 99.90M 52.83M
Receivables 9.15M 9.10M 15.70M 2.26M
Inventories 6.41M 6.17M 2.67M 567.26K
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 161.32M 95.20M 131.03M 63.99M
Property, Plant & Equipment, Gross 12.17M 11.07M 10.38M 7.52M
Accumulated Depreciation & Depletion 9.22M 7.65M 6.68M 5.75M
Property, Plant & Equipment, Net 2.95M 3.42M 3.70M 1.77M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 1.70M 3.18M 0.00 0.00
Total Non-Current Assets 4.66M 6.60M 3.70M 1.77M
Liabilities & Shareholder Equity
Total Assets 165.98M 101.79M 134.73M 65.76M
Accounts Payable 3.00M 3.13M 2.27M 7.56M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 24.33M 25.45M 18.95M 17.30M
Long Term Debt 49.86M 49.77M 29.66M 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 50.43M 46.56M 37.27M 37.56M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 100.29M 96.33M 66.93M 37.56M
Total Liabilities 124.62M 121.78M 85.87M 54.86M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 41.35M -19.99M 48.85M 10.90M
Common Par 126.00K 114.53K 112.71K 103.99K
Additional Paid In Capital 491.69M 361.93M 347.31M 255.82M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -450.43M -382.05M -298.57M -245.02M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -41.00K 17.05K 0.00 0.00
Total Capitalization 91.21M 29.78M 78.52M 10.90M
Total Equity 41.35M -19.99M 48.85M 10.90M
Total Liabilities & Stock Equity 165.98M 101.79M 134.73M 65.76M
Total Common Shares Outstanding 125.72M 114.53M 112.71M 103.99M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 122.69M 112.81M 111.08M 102.57M
Diluted Weighted Shares Outstanding 122.69M 112.81M 111.08M 102.57M
Number of Employees 153 170 152 135
Number of Part-Time Employees 0 0 0 0

HALO Halozyme Therapeutics Inc

Chart of HALO

Analysts Ratings for HALO

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

HALO Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs